Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Vicapsys Life Sciences Total Assets (Quarterly) : 0.1325M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1325M |
| March 31, 2025 | 0.0059M |
| December 31, 2024 | 0.0116M |
| September 30, 2024 | 0.0896M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0397M |
| September 30, 2023 | 0.2085M |
| June 30, 2023 | 0.3781M |
| March 31, 2023 | 0.0633M |
| December 31, 2022 | 0.072M |
| September 30, 2022 | 0.3838M |
| June 30, 2022 | 0.3822M |
| March 31, 2022 | 0.4782M |
| December 31, 2021 | 0.5943M |
| September 30, 2021 | 0.5522M |
| June 30, 2021 | 0.5624M |
| March 31, 2021 | 0.4284M |
| December 31, 2020 | 0.4041M |
| September 30, 2020 | 0.4143M |
| June 30, 2020 | 0.4274M |
| March 31, 2020 | 0.461M |
| December 31, 2019 | 0.6984M |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | 0.7963M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.682M |
| Shareholders Equity (Quarterly) | -3.549M |
| Debt to Equity Ratio | -0.1759 |
| Current Ratio | 0.036 |
| Net Debt Paydown Yield | -0.07% |